bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.07.01.662432

The Effects of Oral Contraceptives on Grip Strength and Neuromuscular Activation During Short-Term Immobilization and Rehabilitation of the Wrist/Hand

Abstract

Females often experience greater weakness following immobilization compared to males. Hormonal fluctuations from the menstrual cycle or oral contraceptive (OC) use may contribute to sex differences and response variation. We examined differences in peak and rapid force and neuromuscular activation among females using monophasic OC and females not using OC following immobilization and rehabilitation. To examine potential sex differences, a male control group was included. Ten males, 10 OC females, and 10 non-OC females (mean {+/-} SD age = 23 {+/-} 3 years) immobilized their left wrist/hand with a brace for one week, followed by [≥] one week of rehabilitation. Participants completed grip tests to assess peak force and the rate of force development (RFD) before and after immobilization and post-rehabilitation, with electromyographic signals recorded from the extensor carpi radialis brevis (ECBR) and flexor digitorum superficialis (FDS). Grip force declined post-immobilization: males = -17.2 {+/-} 10.3%, non-OC = -22.3 {+/-} 24.7%, OC = -20.7 {+/-} 14.8%. No significant time x group interactions were observed for any dependent variables (p > 0.05, 2p [≤] 0.084). Time effects showed recovery post-rehab. RFD, particularly at 200 ms, declined posttest and rebounded post-rehab. ECBR excitation increased post-rehab; FDS trended upward. Only 5 participants required > one week of rehabilitation (2 males, 2 non-OC, 1 OC). We conclude that males and females exhibit similar declines and recovery in grip force after one week of wrist/hand immobilization, regardless of OC use. OC use does not appear to affect outcomes in female patients undergoing musculoskeletal rehabilitation. NEW & NOTEWORTHYPrevious studies report greater strength losses in females than males after immobilization, yet the underlying mechanisms remain unclear. This is the first study to examine whether monophasic OC use influences neuromuscular responses to disuse and recovery. We found no significant differences in the loss or recovery of peak force, RFD, or sEMG excitation between OC users, non-users, and males. Short-term immobilization and rehabilitation outcomes are not meaningfully affected by OC use in healthy, young females.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Stock, M. S., Bauerlein, H. M., Edwards, M. F., Stambaugh, K. E., Parsowith, E. J., Carr, J. C., Smith-Ryan, A. E., Richardson, R. M.. 2025-07-04. The Effects of Oral Contraceptives on Grip Strength and Neuromuscular Activation During Short-Term Immobilization and Rehabilitation of the Wrist/Hand. https://doi.org/10.1101/2025.07.01.662432

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗